Exact Sciences Corp (NASDAQ:EXAS)

76.62
Delayed Data
As of Dec 03
 -3.95 / -4.90%
Today’s Change
74.58
Today|||52-Week Range
159.54
-42.17%
Year-to-Date
Why Is Exact Sciences (EXAS) Down 14.9% Since Last Earnings Report?
Dec 02 / Zacks.com - Paid Partner Content
Exact Sciences Breaks Up With Pfizer -- Time to Buy?
Dec 01 / MotleyFool.com - Paid Partner Content
Zacks Market Edge Highlights: Lululemon, Exact Sciences, Pinterest, PayPal and Shopify
Dec 02 / Zacks.com - Paid Partner Content
Cathie Wood Goes Bargain Shopping -- 3 Troubled Stocks She Just Bought
Nov 29 / MotleyFool.com - Paid Partner Content
Growth Stock Sell-Off: What Should You Do?
Dec 01 / Zacks.com - Paid Partner Content
These 2 Cathie Wood Stocks Are Screaming Buys
Nov 24 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close80.57
Today’s open80.58
Day’s range74.65 - 80.59
Volume91,439
Average volume (3 months)1,533,097
Market cap$14.7B
Data as of 4:00pm ET, 12/03/2021

Growth & Valuation

Earnings growth (last year)-777.37%
Earnings growth (this year)+42.31%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)+70.19%
P/E ratioNM
Price/Sales13.43
Price/Book4.83

Competitors

 Today’s
change
Today’s
% change
NVAXNovavax Inc-1.49-0.92%
BMRNBiomarin Pharmaceuti...-1.69-2.00%
----
TECHBio-Techne Corp-11.10-2.38%
Data as of 6:17pm ET, 12/03/2021

Financials

Next reporting dateFebruary 24, 2022
EPS forecast (this quarter)-$0.85
Annual revenue (last year)$1.5B
Annual profit (last year)-$848.5M
Net profit margin-56.90%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Madison, Wisconsin

Forecasts